Reviewing Medical Cannabis Payment Solutions (OTCMKTS:REFG) & Payoneer Global (NASDAQ:PAYO)

Payoneer Global (NASDAQ:PAYO) and Medical Cannabis Payment Solutions (OTCMKTS:REFG) are both business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Payoneer Global and Medical Cannabis Payment Solutions, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Payoneer Global	0	1	5	1	3.00
Medical Cannabis Payment Solutions	0	0	0	0	0.00

Payoneer Global presently has a consensus target price of $11.36, indicating a potential upside of 14.37%. Given Payoneer Global’s stronger consensus rating and higher possible upside, equities analysts clearly believe Payoneer Global is more favorable than Medical Cannabis Payment Solutions.

Profitability

This table compares Payoneer Global and Medical Cannabis Payment Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Payoneer Global	13.82%	17.78%	1.73%
Medical Cannabis Payment Solutions	N/A	N/A	N/A

Volatility & Risk

Payoneer Global has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500. Comparatively, Medical Cannabis Payment Solutions has a beta of -0.13, meaning that its share price is 113% less volatile than the S&P 500.

Earnings and Valuation

This table compares Payoneer Global and Medical Cannabis Payment Solutions”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Payoneer Global	$940.30 million	3.77	$93.33 million	$0.35	28.37
Medical Cannabis Payment Solutions	$140,000.00	N/A	-$30,000.00	N/A	N/A

Payoneer Global has higher revenue and earnings than Medical Cannabis Payment Solutions.

Institutional and Insider Ownership

82.2% of Payoneer Global shares are owned by institutional investors. 5.6% of Payoneer Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Payoneer Global beats Medical Cannabis Payment Solutions on 12 of the 12 factors compared between the two stocks.

About Payoneer Global

Payoneer Global Inc. operates as a financial technology company. It operates a payment infrastructure platform that provides customers with a one-stop, global, multi-currency account to serve their accounts receivable and accounts payable needs. The company delivers a suite of services that includes cross-border payments, physical and virtual MasterCard cards, working capital, risk management, and other services. It also offers various payment options with minimal integration required, full back-office functions, and customer support offered. The company's platform delivers bank-grade security, stability, and redundancy. It serves customers, such as small and medium-sized businesses in approximately 190 countries and territories worldwide. Payoneer Global Inc. was founded in 2005 and is headquartered in New York, New York.

About Medical Cannabis Payment Solutions

Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming. On August 12, 2024, Medical Cannabis Payment Solutions, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Western District of Pennsylvania.